Education Events

COGNO Masterclass: Management of Low-Grade Glioma

2025-05-24

Brought to you by the COGNO Outreach and Education Committee.

Gliomas are the most common form of brain cancer in Australia. Implementing effective early detection and management strategies is essential to improving outcomes and enhancing the quality of life for those affected.

This masterclass aims to provide clinicians and trainees with an in-depth, multidisciplinary understanding of current and emerging strategies in the management of low-grade glioma (LGG), with a focus on IDH-mutant gliomas, through expert-led lectures and interactive case-based discussions.At the conclusion of this masterclass, participants will be able to:

  • Understand the clinical aspects of low-grade glioma and their implications for diagnosis and treatment.
  • Interpret relevant neuroimaging, histopathology and molecular findings to help inform clinical decision-making.
  • Apply current best-practice approaches to the management of low-grade glioma, including surgical, radiotherapeutic, and medical strategies.
  • Implement multidisciplinary perspectives to real-world clinical scenarios through interactive case discussions.
  • Recognise current challenges and emerging trends shaping the future of low-grade glioma management.
Sponsored by

Chairs

Dr. Laveniya Satgunaseelan

Dr. Laveniya Satgunaseelan

Chair

Neuropathologist (NSW)

Dr Laveniya Satgunaseelan is a pathologist in the Department of Neuropathology at Royal Prince Alfred Hospital, Sydney. Her main role is in the provision of molecular neuropathology services. She is the current secretary/treasurer of the Australia and New Zealand Society for Neuropathology. Her interests include cancer genomics and health equity in pathology.

Dr. Joseph Sia

Dr. Joseph Sia

Chair

Radiation Oncologist (VIC)

Joe Sia is a Radiation Oncologist in the Neuro-Oncology Unit at the Peter MacCallum Cancer Centre and a Senior Clinical Research Fellow at WEHI. He did his medical training in New Zealand, radiation oncology training and laboratory-based PhD in Australia. He leads the Neuro-Oncology Translational Radiobiology Research Programme, a collaboration between Peter Mac and WEHI.

Speakers

Dr Edward Chan

Dr Edward Chan

Speaker

Neuroradiologist (NSW)

Dr Edward Chan is a neuroradiologist with a public appointment at Liverpool Hospital in Sydney and works in private practice. While completing his MBBS at the University of Sydney, he concurrently obtained a MPhil for his published research on intracranial haemorrhage. Following general radiology training at Liverpool Hospital and various other major tertiary hospitals in Sydney, he embarked on a neuroradiology fellowship at Monash Health and regularly participated in the neuro-oncology, neuroscience and head and neck oncology multidisciplinary meetings.

Prof Frank Saran

Prof Frank Saran

Speaker

Radiation Oncologist (SA)

Prof. Saran a senior radiation oncologist in Adelaide, South Australia, and has three decades of experience managing paediatric and adult patients with primary and secondary CNS tumours as well as other rare cancers.

Prof. Saran graduated at the University of Düsseldorf in Germany in 1992 and completed his training as clinical oncology. After a clinical research fellowship in London, he has worked as a consultant clinical oncologist at Velindre Hospital Cardiff (UK), the Royal Marsden Hospital London (UK), Auckland City Hospital Auckland (NZ) and the Royal Adelaide Hospital Adelaide. In addition, he holds an appointment at the Australian Bragg Centre for Proton Therapy and Research (ABCPTR) and is an appointed Adjunct Clinical Professor at the University of South Australia.

Prof. Saran has been a recognised national and international speaker and has given keynote lectures at meetings around the world.

Dr Krishnan Iyengar

Dr Krishnan Iyengar

Speaker

Neuropathologist (QLD)

Dr Krishnan Iyengar is a Neuropathologist working for Pathology Queensland, RBWH, Herston. He has over 30 years’ experience as a specialist pathologist in Australia and overseas. Having previously worked in cytopathology, genitourinary pathology and dermatopathology, his current area of interest is neuro-oncology as well as all other aspects of neuropathology. He has research publications in international journals in these fields.

Ms Marina Kastelan

Ms Marina Kastelan

Speaker

Nurse Practitioner (NSW)

Marina is the Neuro Oncology Nurse Practitioner based at North Shore Private Hospital in Sydney.

She completed a Master of Nursing, Nurse Practitioner & is currently endorsed as an NP in NSW. She has been in her current role since 2008 – this role encompasses coordination & management of newly diagnosed primary brain tumour patients; including education & coordination through the often difficult & confusing multiple modalities of ongoing treatment. As well as the patient, there is a great focus on supporting the Caregivers of people with primary brain tumours also.

Dr Richard Shaw

Dr Richard Shaw

Speaker

Neurosurgeon (NSW)

Dr Richard Shaw is a Sydney-based neurosurgeon currently working at Royal Prince Alfred Hospital and Chris O'Brien Lifehouse. In 2019, he was selected as the top candidate in Australia and New Zealand to commence advanced neurosurgical training.

During this time, he also served on the neurosurgical Surgical Education and Training board as the sole trainee representative in 2022. Dr Shaw has a subspecialty interest in complex brain tumours, including intra-operative adjuncts to optimise resection safety and efficiency. He is due to travel to Dallas, Texas next month to complete a fellowship in open and endoscopic skullbase oncology and cerebrovascular surgery.

Dr Alex Yuile

Dr Alex Yuile

Speaker

Medical Oncologist (NSW)

Dr Alex Yuile is a Medical Oncologist with a keen interest in primary brain tumours. After completing his fellowship in neuro-oncology and translational research at Royal North Shore Hospital he began his PhD focusing on IDH-mutant gliomas. Dr Yuile is currently working as a neuro-oncologist at Royal North Shore Hospital and has particular interest in IDH-mutant gliomas and neuro-oncology clinical trials. He is a member of the Scientific Advisory Committee for the Co-operative Trials Group for Neuro-Oncology and the EviQ Neuro-Oncology Reference Committee.

Others Education Events

Education Events

2026-05-09
Brought to you by the COGNO Education Committee. ‘From Idea to Trial Concept’ is the first in a new series of COGNO skills development workshops, designed to build research capacity across the neuro-oncology community. This half-day workshop is aimed at those who are interested in developing a neuro-oncology clinical trial but are at the early stages of that journey. The session will take participants through the process of moving from an initial idea to a coherent, well-framed trial concept.

Education Events

2025-12-03
Join us for an exclusive virtual recap of the latest breakthroughs in brain cancer research and treatment emerging presented at the 7th World Federation of Neuro-Oncology Societies (WFNOS) and 30th Society for Neuro-Oncology(SNO) Meetings in Honolulu, Hawaii. This webinar will highlight the most impactful updates with a focus on clinical relevance and research trends. Speakers attending the event and expert panel will explore the latest findings with an Australian lens. Stay tuned for the video recording, available to all COGNO members.

Education Events

2024-12-10
Join local neuro-oncology experts for a review of the latest and most significant international treatment and research findings in brain cancer presented at this year’s Society for Neuro-Oncology Meeting in Houston, Texas. Our expert panel will review the latest in translational science, and clinical updates in low grade glioma and glioblastoma. Drawing on a panel of clinicians and scientist from across Australia, this is a great opportunity to hear their perspectives on how these advances may impact brain cancer care in Australia.

Your donations to our Brain Tumour research make a real difference